Literature DB >> 15939368

Capillaroscopy.

Maurizio Cutolo1, Carmen Pizzorni, Alberto Sulli.   

Abstract

Raynaud's phenomenon (RP) is the most common and significant clinical condition with an indication for a microvascular analysis to be carried out as soon as possible. Microvascular involvement is a key feature of RP and several rheumatic diseases are characterised by the presence of RP. Nailfold capillary microscopy shows an impressive cost/effectiveness ratio: it is simple, non-invasive and inexpensive. Well recognised nailfold videocapillaroscopic patterns (NVC) have been described mainly in systemic sclerosis (SSc) patients with secondary RP. The peripheral microvascular damage in SSc is characterised by increasing structural alterations of the capillaries (giant capillaries and microhaemorrhagies) with a progressive decrease in their density. The detection of the scleroderma NVC pattern allows an early distinction between the primary RP (functional, not disease associated) and the secondary RP (disease associated). Other major NVC patterns have been described in the field of rheumatic diseases. Interestingly, correlations are evident between the NVC and the clinical symptoms, severity of the disease and the laboratory findings.

Entities:  

Mesh:

Year:  2005        PMID: 15939368     DOI: 10.1016/j.berh.2005.01.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  21 in total

1.  Comparison of qualitative and quantitative analysis of capillaroscopic findings in patients with rheumatic diseases.

Authors:  Sevdalina Nikolova Lambova; Walter Hermann; Ulf Müller-Ladner
Journal:  Rheumatol Int       Date:  2011-12-07       Impact factor: 2.631

2.  Primary care assessment of capillaroscopy abnormalities in patients with Raynaud's phenomenon.

Authors:  Rebecca Overbury; Maureen A Murtaugh; Aryeh Fischer; Tracy M Frech
Journal:  Clin Rheumatol       Date:  2015-09-23       Impact factor: 2.980

3.  Nailfold capillaroscopy in Behçet's disease, analysis of 128 patients.

Authors:  Atusa Movasat; Farhad Shahram; Patricia E Carreira; Abdolhadi Nadji; Maassoomeh Akhlaghi; Nassim Naderi; Fereydoun Davatchi
Journal:  Clin Rheumatol       Date:  2009-02-14       Impact factor: 2.980

4.  Nailfold capillaroscopy in rheumatology: ready for the daily use but with care in terminology.

Authors:  Maurizio Cutolo; Sabrina Paolino; Vanessa Smith
Journal:  Clin Rheumatol       Date:  2019-08-08       Impact factor: 2.980

Review 5.  [Capillary microscopy].

Authors:  W Hermann
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

6.  Is there an association between glaucoma and capillaroscopy in patients with systemic sclerosis?

Authors:  Beatriz Fiuza Gomes; Rebeca Souza; Thiago Valadão; Newton Kara-Junior; Haroldo Vieira Moraes; Marcony R Santhiago
Journal:  Int Ophthalmol       Date:  2017-05-06       Impact factor: 2.031

Review 7.  Assessing microvascular changes in systemic sclerosis diagnosis and management.

Authors:  Maurizio Cutolo; Alberto Sulli; Vanessa Smith
Journal:  Nat Rev Rheumatol       Date:  2010-08-10       Impact factor: 20.543

8.  Capillaroscopic pattern in systemic lupus erythematosus and undifferentiated connective tissue disease: what we still have to learn?

Authors:  Sevdalina Nikolova Lambova; Ulf Müller-Ladner
Journal:  Rheumatol Int       Date:  2012-04-24       Impact factor: 2.631

9.  Cyclophosphamide treatment improves microvessel damage in systemic sclerosis.

Authors:  Paola Caramaschi; Alessandro Volpe; Sara Pieropan; Ilaria Tinazzi; Helal Mahamid; Lisa Maria Bambara; Domenico Biasi
Journal:  Clin Rheumatol       Date:  2008-12-04       Impact factor: 2.980

10.  Exercise and Repeated Testing Improves Accuracy of Laser Doppler Assessment of Microvascular Function Following Shortened (1-minute) Blood Flow Occlusion.

Authors:  Brian D Tran; Abraham Chiu; Charlene Tran; Danica Rose Rogacion; Nicole Tfaye; Goutham Ganesan; Pietro R Galassetti
Journal:  Microcirculation       Date:  2016-05       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.